Clinical Implications of Baroreflex Sensitivity in Type 2 Diabetes

Area of Science:

• Cardiology
• Endocrinology
• Autonomic Neuroscience

Background:

• Baroreflex sensitivity (BRS) is vital for maintaining cardiovascular autonomic homeostasis and blood pressure regulation.
• Reduced BRS is a hallmark of cardiovascular autonomic neuropathy, particularly in type 2 diabetes mellitus (T2DM).
• A vicious cycle exists where reduced BRS increases blood pressure variability, further diminishing BRS.

Purpose of the Study:

• To review the features of reduced BRS in T2DM.
• To explore the independent role of glycemic variability (GV) in BRS reduction.
• To discuss potential strategies for reversing reduced BRS in T2DM patients.

Main Methods:

• This is a review article, synthesizing existing research on BRS and T2DM.
• Analysis of studies investigating risk factors for reduced BRS.
• Examination of literature linking glycemic variability to cardiovascular complications.

Main Results:

• Type 2 diabetes mellitus and essential hypertension are primary risk factors for reduced BRS.
• Glycemic variability (short- and long-term) is increasingly recognized as an independent contributor to BRS reduction, irrespective of average glucose levels.
• Reduced BRS is associated with increased blood pressure variability, exacerbating the condition.

Conclusions:

• Reduced BRS is a significant issue in T2DM, linked to glycemic variability.
• Understanding the interplay between T2DM, GV, and BRS is crucial for managing cardiovascular risk.
• Further research into reversing BRS reduction in T2DM holds therapeutic potential.